August, 03 2025 Sunday 12:06 Hrs
  • SENSEX :   80,599.91

  • Top commodity trading and broking companies in India-585.67( -0.72%) 01-Aug-2025
top-arrow-market
Sensex 80599.91 -585.67  (-0.72) 01-Aug-2025
Previous Day Close
81185.58
Today's High/Low
High Low
  •  
  •  
81317.51 80495.57

Company News Details

Cohance Lifesciences Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
543064
INE03QK01018
60.8611266
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
COHANCE
138.08
37506.88
EPS(TTM)
Face Value()
Div & Yield %
7.1
1
0
 

Cohance Lifesciences appoints Yann D'Herve as CEO - CDMO Business
Jul 28,2025
The Board of Cohance Lifesciences has appointed Yann D'Herve as Chief Executive Officer – CDMO Business, and Senior Management Personnel of the Company, with effect from 01 August 2025. Yann will be based out of New Jersey, United States of America.
Top
Attention Investor:
Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers/Depository Participant.     KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, ,Mutual ).    No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.